NextCure, Inc. (NXTC)
$6.28-5.42%Close
BUYRECOVERY · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $23M
- Beta
- 1.35
- P/E (TTM)
- -0.59
- Short % float
- 9.44%
- Days to cover
- 1.9
- SI change
- +102.7%
- 1W
- +10.37%
- 1M
- -5.42%
- vs SPY 1W
- +10.51%
- vs SPY 1M
- -7.93%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on NXTC?
- LOPJLB’s latest quantitative signal on NextCure, Inc. (NXTC) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is NXTC in?
- NextCure, Inc. (NXTC) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does NextCure, Inc. (NXTC) do?
- NextCure, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative immunotherapies. Its core mission is to combat cancer and various other immune-related conditions by reactivating normal immune system function. The company's leading investigational compound, NC318, is currently in Phase II clinical trials, focusing on the treatment of advanced or metast…